Generic Name and Formulations:
Phenylephrine 1%, ketorolac 0.3%; intraocular soln after dilution.
Indications for OMIDRIA:
To maintain pupil size by preventing intraoperative miosis and reducing post-op ocular pain during cataract surgery or intraocular lens replacement, when added to an ocular irrigating solution.
Adults and Children:
Dilute 4mL of solution in 500mL of ocular irrigating solution. Use as needed for surgical procedure.
May elevate blood pressure. Aspirin or NSAID sensitivity. History of asthma. Pregnancy (avoid in 3rd trimester). Nursing mothers.
Alpha-1 agonist + NSAID.
Eye irritation, posterior capsule opacification, increased intraocular pressure, anterior chamber inflammation.
Single-patient-use vials (4mL)—4, 10
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Congress Passes Bill to Fight Opioid Crisis
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure